World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0003307839
Reproduction Date:

Title: Dihydromorphine  
Author: World Heritage Encyclopedia
Language: English
Subject: Nicocodeine, Opioid, Diacetyldihydromorphine, Nicomorphine, List of opioids
Collection: Alcohols, Euphoriants, Morphinans, Mu-Opioid Agonists, Opioids, Phenols, Semisynthetic Opioids
Publisher: World Heritage Encyclopedia


Skeletal formula of dihydromorphine
Ball-and-stick model of the dihydromorphine molecule
Systematic (IUPAC) name
Clinical data
Legal status
Routes of
Oral, Intravenous, Intranasally, Sublingually
CAS Registry Number  N
ATC code None
PubChem CID:
DrugBank  Y
ChemSpider  Y
Synonyms Dihydromorphine, Paramorphan
Chemical data
Formula C17H21NO3
Molecular mass 287.354 g/mol

Dihydromorphine (Paramorfan, Paramorphan) is a semi-synthetic opioid structurally related to and derived from morphine. The 7,8-double bond in morphine is reduced to a single bond to get dihydromorphine.[1] Dihydromorphine is a moderately strong analgesic and is used clinically in the treatment of pain and also is an active metabolite of the analgesic opioid drug dihydrocodeine.[2][3][4] Dihydromorphine occurs in trace quantities in assays of opium on occasion, as does dihydrocodeine, dihydrothebaine, tetrahydrothebaine, etc. The process for manufacturing dihydromorphine from morphine for pharmaceutical use was developed in Germany in the late 19th Century, with the synthesis being published in 1900 and the drug introduced clinically as Paramorfan shortly thereafter. A high-yield synthesis from tetrahydrothebaine was later developed[5]


  • Uses 1
    • Medical 1.1
    • Research 1.2
  • Strength 2
  • Pharmacology 3
    • Pharmacokinetics 3.1
  • Legality 4
    • United States of America 4.1
    • Europe 4.2
    • Japan 4.3
  • See also 5
  • References 6
  • External links 7



Dihydromorphine is an opioid that is used for the management of moderate to severe pain such as cancer, although its less effective in treating things such as neuropathic pain and is generally considered inappropriate and ineffective for psychological pain.[2][6]


Dihydromorphine, often labelled with the isotope tritium in the form of [3H]-dihydromorphine, is used in scientific research to study binding of the opioid receptors in the nervous system.[7][8]


Dihydromorphine is slightly stronger than morphine as an analgesic with a similar side effect profile. The relative potency of dihydromorphine is about 1.2 times that of morphine. In comparison, the relative potency of dihydrocodeine is 1.15 times that of codeine.[9]


Dihydromorphine acts as an agonist at the μ-opioid (mu), δ-opioid (delta) and κ-opioid (kappa) receptors.[2][3] Agonist of the μ-opioid and δ-opioid receptors is largely responsible for the clinical effects of opioids like dihydromorphine with the μ agonism providing more analgesia than the δ.[10][11]


Dihydromorphine's onset of action is more rapid than morphine and it also tends to have a longer duration of action, generally 4–7 hours.


Under the 1961 international Single Convention on Narcotic Drugs treaty dihydromorphine is a Schedule I narcotic subject to control, and other countries' laws may vary.[12]

United States of America

Under the Controlled Substances Act, dihydromorphine is listed as a Schedule I substance along with heroin.[13] In the United States, its role in the production of dihydrocodeine and other related drugs make it a Schedule I substance with one of the higher annual manufacturing quotas granted by the US Drug Enforcement Administration—3300 kilos in 2013; manufacturers, distributors, and importers with the correct DEA license and state permits related thereto are able to use Schedule I drugs in this fashion when they are transformed into something of a lower schedule.[14] The DEA has assigned dihydromorphine and all of its salts, esters, &c the ACSCN of 9145. As with nicomorphine, MDMA, heroin (DEA 2013 production quota: 25 grammes)[15] and the like, dihydromorphine is also used in research such as that mentioned above in properly licensed facilities; Form 225, the most common and least expensive individual researcher's license, does not include Schedule I so the lab must have a higher-level DEA registration [16] As with other licit opioids used for medical purposes in other countries, including even much weaker opioids like nicocodeine, benzylmorphine, and tilidine, the reason that dihydromorphine is in Schedule I is that it was not in medical use in the USA at time the Controlled Substances Act 1970 was drawn up.


Dihydromorphine is regulated in the same fashion as morphine in Germany under the BtMG,[17] Austrian SMG,[18] and Swiss BtMG, where it is still used as an analgesic.[19] The drug was invented in Germany in 1900 and marketed shortly thereafter. It is often used in Patient Controlled Analgesia units.[20][21]


Dihydromorphine and morphine are also used alongside each other in clinical use in Japan and is regulated as such [22]

See also


  1. ^ Rama Rao Nadendla. Principles Of Organic Medicinal Chemistry pp. 215
  2. ^ a b c DrugBank: Dihydromorphine (DB01565)
  3. ^ a b Dihydromorphine - PubChem
  4. ^ Susanne Ammon, Ute Hofmann, Ernst-Ulrich Griese, Nadja Gugeler, and Gerd Mikus (1999). "Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing". British Journal of Clinical Pharmacology 48 (3): 317–322.  
  5. ^
  6. ^ Dureja. Handbook Of Pain Management pp. 67
  7. ^ Antkiewicz-Michaluk L, Vetulani J, Havemann U, Kuschinsky K (1982). "3H-dihydromorphine binding sites in subcellular fractions of rat striatum.". Pol J Pharmacol Pharm 34 (1-3): 73–78.  
  8. ^ Savage DD, Mills SA, Jobe PC, Reigel CE (1988). "Elevation of naloxone-sensitive 3H-dihydromorphine binding in hippocampal formation of genetically epilepsy-prone rats.". Life Sci. 43 (3): 239–246.  
  9. ^ Rama Rao Nedendla. Principles Of Organic Medicinal Chemistry pp. 216
  10. ^ Costantino CM, Gomes I, Stockton SD, Lim MP, Devi LA (2012). "Opioid receptor heteromers in analgesia.". Expert Rev Mol Med 14 (9): e9.  
  11. ^ Varga EV, Navratilova E, Stropova D, Jambrosic J, Roeske WR, Yamamura HI (2004). "Agonist-specific regulation of the delta-opioid receptor". Life Sci. 76 (6): 599–612.  
  12. ^ Single Convention on Narcotic Drugs, 1961 - Page 40 of 44
  13. ^ Controlled Substances (in alphabetical order) - Page 5 of 12
  14. ^ DEA Website: Forms, Retrieved 26. April 2014
  15. ^ Federal Register, linked from DEA site
  16. ^ DEA Web Site, retrieved 30. April 2014
  17. ^ Deutsche Betäbungsmittelgesetz, accessed 27. April 2014
  18. ^ SMG, 30. April 2014
  19. ^ UNODC Bulletin On Narcotics, 1953, Issue 2
  20. ^ Opioids for Pain Control (Cambridge Press, 2002)
  21. ^ Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10th Edition5n
  22. ^ UNODC Bulletin On Narcotics, 1955

External links

  • Various information about dihydromorphine at the DrugBank
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.